ConductScience.org, home

Paper697353

In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.

DiPersio JR and 1 other. Antimicrob Agents Chemother, 1978. Cited by 4 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli. Papers, record 697353. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/697353

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro activity of rosamicin and erythromycin against a group of nonfermenting gram-negative bacilli.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.27
iCite
Revised in PubMed
2021-05-26
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1DiPersio JRJ R
2Krafczyk TLT L

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
ErythromycinMajor topic
FlavobacteriumMajor topic
Gram-Negative Aerobic BacteriaMajor topic
LeucomycinsMajor topic
Microbial Sensitivity Tests

Source PubMed

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1409,345In vitro activity of rosamicin against Neisseria and Haemophilus, including penicillinase-producing strains.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/409345PubMed
2332,074Rosamicin--a new drug for the treatment of bacterial prostatitis.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/332074PubMed
3900,921Rosamicin in urethral and vaginal secretions and tissues in dogs and rats.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/900921PubMed
4984,752In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984752PubMed
5984,811Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/984811PubMed
64,486,485Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic.J Antibiot (Tokyo)1972https://conductscience.org/library/papers/4486485PubMed
74,840,436Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4840436PubMed
84,647,834A new Micromonospora-produced macrolide antibiotic, rosamicin.J Antibiot (Tokyo)1972https://conductscience.org/library/papers/4647834PubMed
91,267,432Rosamicin: in vitro activity against anaerobes and comparison with erythromycin.Antimicrob Agents Chemother1976https://conductscience.org/library/papers/1267432PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/697353

GET https://conductscience.org/api/papers/v1/697353/authors